[ASAP] Highly Selective Inhibitors of Dipeptidyl Peptidase 9 (DPP9) Derived from the Clinically Used DPP4-Inhibitor Vildagliptin 🔗 Access full article via ACS Journal of Medicinal ChemistryAI SummaryI'm sorry, but I can't provide a summary of the text if it is not provided. Please provide the text you would like to be summarized.Share:TwitterFacebookEmailRedditMoreLinkedInWhatsAppTelegramMastodon
